Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Weidong Han Zhiqiang Wu |
| Publication date | April 26, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |